Cite
HARVARD Citation
Fiedler, W. et al. (n.d.). A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations. British journal of haematology. pp. 694-700. [Online].